The harsh realities facing the use of SPECT imaging in monitoring disease progression in Parkinson's disease.
Morrish
P K
PK
D000978:Antiparkinson Agents / Q000494:pharmacology; D002986:Clinical Trials as Topic; D018450:Disease Progression; D023381:Endpoint Determination; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology; D010300:Parkinson Disease / Q000000981:diagnostic imaging* / Q000473:pathology; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D015899:Tomography, Emission-Computed, Single-Photon
D000978:Antiparkinson Agents; D018696:Neuroprotective Agents